Vaccine Against Brain Tumors Shows Promising Long-Term Results: 33 patients with high-grade astrocytomas, the most common form of glioma, received vaccine that trains the immune system to recognize and fight tumor cells. 66% were still alive after 8 years, and in 42%, the disease had not progressed.
dkfz.de